CND Life Sciences, Inc. research brief

CIK 1841099 Copy CIK

Generated Nov. 7, 2026, 4:08 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: SCOTTSDALE AZ. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Aug. 3, 2026 · D/A · 0001841099-26-000002 · Source evidence

  Reported offering amount: 6316514 USD. Reported amount sold: 6316514 USD.

• June 16, 2026 · D · 0001841099-26-000001 · Source evidence

  Reported offering amount: 6250000 USD. Reported amount sold: 4314750 USD.

• May 6, 2025 · D/A · 0001841099-25-000004 · Source evidence

  Reported offering amount: 9000000 USD. Reported amount sold: 8648469 USD.

• April 15, 2025 · D/A · 0001841099-25-000003 · Source evidence

  Reported offering amount: 9000000 USD. Reported amount sold: 3664565 USD.

• March 6, 2025 · D · 0001841099-25-000001 · Source evidence

  Reported offering amount: 7500000 USD. Reported amount sold: 3514565 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “CND Life Sciences, Inc. research brief,” CIK 1841099, retrieved Nov. 7, 2026, 4:08 a.m.. Cite the specific accessions used. No amounts have been summed.